Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 50040113
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389319(CHEMBL2063924)
Affinity DataIC50: 2nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50380257(CHEMBL2017253)
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50380246(CHEMBL2017214)
Affinity DataIC50: 12nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389323(CHEMBL2063925)
Affinity DataIC50: 15nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389321(CHEMBL2063927)
Affinity DataIC50: 28nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389322(CHEMBL2063929)
Affinity DataIC50: 30nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389311(CHEMBL2063916)
Affinity DataIC50: 40nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389318(CHEMBL2063923)
Affinity DataIC50: 43nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 48nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389307(CHEMBL2063928)
Affinity DataIC50: 50nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389309(CHEMBL2063914)
Affinity DataIC50: 58nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389312(CHEMBL2063917)
Affinity DataIC50: 66nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389308(CHEMBL2063913)
Affinity DataIC50: 70nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389310(CHEMBL2063915)
Affinity DataIC50: 110nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389319(CHEMBL2063924)
Affinity DataIC50: 150nMAssay Description:Inhibition of KHKC in human HepG2 cells assessed as level of fructose-1-phosphateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389314(CHEMBL2063919)
Affinity DataIC50: 300nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389313(CHEMBL2063918)
Affinity DataIC50: 440nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50380246(CHEMBL2017214)
Affinity DataIC50: 500nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389316(CHEMBL2063921)
Affinity DataIC50: 800nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389315(CHEMBL2063920)
Affinity DataIC50: 4.60E+3nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389317(CHEMBL2063922)
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of GSK3B by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetProtein kinase C theta type(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PRKCQ by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase 26(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of MST4 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetAurora kinase A(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AURKA by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CHEK2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AMPK A1/B1/G1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPlatelet-derived growth factor receptor beta(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PDGFRB by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of NTRK1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ABL1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of JAK2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of RPS6KA3 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetRAC-alpha serine/threonine-protein kinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of AKT1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetMitogen-activated protein kinase 13(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of MAPK13 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PLK3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PLK3 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase PAK 3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PAK3 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCalcium/calmodulin-dependent protein kinase type 1D(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CAMK1D by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetActivin receptor type-1B(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ALK4 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetRho-associated protein kinase 1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ROCK1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Nek2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of NEK2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetDeath-associated protein kinase 3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of DAPK3 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CDK1/cyclin B by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetcAMP-dependent protein kinase catalytic subunit alpha(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PRKACA by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase pim-2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PIM2 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CHEK1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of IRAK4 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetEphrin type-B receptor 1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of EPHB1 by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetEpidermal growth factor receptor(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of EGFR by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CSNK1D by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetInsulin receptor(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of INSR by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: